• EN

Please note that the information on this page is based on the EMCDDA Annual report 2010: the state of the drugs problem in Europe. Most statistical data relate to the year 2008 (or the last year available).

Annual report 2010: the state of the drugs problem in Europe
New drugs and emerging trends

Published: 10 November 2010


New psychoactive substances and new patterns of use, though usually first appearing among restricted social groups or in a few locations, can have important implications for public health and for drug policy. Providing timely and objective information to policymakers, professionals and the wider public on new threats is methodologically and practically challenging. And it is of growing importance, given the increasingly dynamic and fast-moving nature of the European drugs problem. The European Union’s early-warning system has been developed as a rapid-response mechanism to the emergence of new psychoactive substances on the drug scene.

A large number of new unregulated synthetic compounds have appeared in recent years. These substances are marketed on the Internet as ‘legal highs’ and are designed to circumvent drug controls. They constitute a challenge to current approaches for monitoring and controlling new psychoactive substances. As reviewed in this chapter, the last two years have seen the emergence of new, smokable herbal products laced with synthetic cannabinoids and the growing popularity of various synthetic cathinones.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact us

Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 15 October 2010